{"database": "lobbying", "table": "lobbying_activities", "rows": [[1728003, "9299dc28-1e19-47c5-961b-0a0e88cebaeb", "Q3", "PHARMAVITE LLC", 286074, "PHARMAVITE LLC", 2015, "third_quarter", "FOO", "1) Adequate FDA funding to fully enforce DSHEA, inspect dietary supplement manufacturers, take enforcement action against clear violations of law and carryout other required regulatory activities\n2) New Dietary Ingredient Guidance - prompt publication of second draft guidance of this document from FDA\n3) Full implementation by DEA of HR/4771 and S2012 Designer Anabolic Steroid Control Act\n4) Shared information about key nutrient shortfalls based on NHANES data", "HOUSE OF REPRESENTATIVES,SENATE", null, 50000, 0, 0, "2015-10-09T16:29:36-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1728003"], "units": {}, "query_ms": 15.821852022781968, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}